2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects
Chu Hsien Lim, Brian D. Kangas, Jack Bergman
July 9, 2018 DOI: 10.22186/jyi.35.2.45-49 via OpenAlex
Summary
AI-generated from the abstractCancer patients face elevated rates of depression and anxiety, often leading to worse healthcare outcomes. Given limited treatment options, interest has grown in using psychedelics like psilocybin to manage these complications. Recent studies have shown the potential of psilocybin to alleviate depression and anxiety in cancer patients.
Study at a glance
| Characteristics | Review |
|---|---|
| Population | Cancer patients |
| Intervention | Psilocybin |
| Topics | Anxiety Psilocybin |
| Keywords | Breast cancer Depression economics Intensive care medicine |
| Citations | 1 |
| Key finding | Psilocybin shows potential for managing depression and anxiety in cancer patients. |
Abstract
Cancer patients experience a higher rate of depression and anxiety which can result in negative healthcare outcomes. With the limited treatment options available, there has been an interest in using psychedelics such as psilocybin to manage such complications. Recently, two studies demonstrated the